About the Imaging Research laboratory
The Imaging Research laboratory is dedicated to ensuring cardiovascular imaging delivers maximum value for patients — developing pathways for better integration of imaging with clinical management to improve diagnosis, treatment decisions and outcomes.
Cardiovascular imaging technologies have advanced dramatically, but their potential to improve patient care depends on how effectively they're used in clinical practice. Our research addresses critical questions:
- How can we provide equity of access, including to rural and remote areas?
- Which imaging approaches provide the best information for clinical decisions?
- How can we detect cardiovascular disease earlier, when intervention is most effective?
- How do we ensure imaging is used appropriately and cost-effectively across the healthcare system?
By answering these questions, we're working to make cardiovascular imaging not just more sophisticated, but more useful — translating technological capabilities into better care for patients.
Research focus
Early cardiovascular disease detection
Using echo and CT for risk evaluation and intervention based on detecting early-stage cardiovascular disease, enabling treatment before significant damage occurs.
AI and robotics
Advances in artificial intelligence (AI) have enabled imaging to be performed and even interpretated by non-experts. Our investigations seek to define how and when these can be safely used, and when remote expertise can be delivered by robotics.
Quality, appropriate use and cost-effectiveness
Ensuring cardiovascular imaging is used appropriately, delivers high-quality information, and provides value within the healthcare system.
New imaging modalities
Evaluating emerging cardiovascular imaging technologies to determine their clinical utility and optimal applications.
Community engagement
We collaborate with the Baker Institute's Community Engagement Group to embed meaningful consumer and community voices into our research. This engagement has helped shape our study direction, refine recruitment and messaging, and support more relevant, accessible and impactful outcomes for people affected by cardiovascular disease, particularly those who may benefit from early detection through advanced imaging.